Skip to main content

Advertisement

SpringerLink
Log in

2006 drug approvals: finding the niche

  • News and Analysis
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

An Erratum to this article was published on 01 March 2007

Abstract

Companies move towards niche products to boost productivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: FDA drug approvals.
Figure 2: Priority reviews and orphan drugs.
Figure 3: 2006 Drug approvals by therapeutic area.
Authors
  1. Joanna Owens
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Owens, J. 2006 drug approvals: finding the niche. Nat Rev Drug Discov 6, 99–101 (2007). https://doi.org/10.1038/nrd2247

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd2247

  • Springer Nature Limited

This article is cited by

Search

Navigation